Zhejiang Medicine Co Ltd
SSE:600216

Watchlist Manager
Zhejiang Medicine Co Ltd Logo
Zhejiang Medicine Co Ltd
SSE:600216
Watchlist
Price: 17.39 CNY -1.75% Market Closed
Market Cap: 16.7B CNY
Have any thoughts about
Zhejiang Medicine Co Ltd?
Write Note

Relative Value

The Relative Value of one Zhejiang Medicine Co Ltd stock under the Base Case scenario is 12.51 CNY. Compared to the current market price of 17.39 CNY, Zhejiang Medicine Co Ltd is Overvalued by 28%.

Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

Relative Value
Base Case
12.51 CNY
Overvaluation 28%
Relative Value
Price
Worst Case
Base Case
Best Case

Valuation Multiples

vs History
7
vs Industry
61
Median 3Y
1.4
Median 5Y
1.6
Industry
2.6
Forward
1.7
vs History
9
vs Industry
16
Median 3Y
22.5
Median 5Y
22.6
Industry
23
Forward
17.3
vs History
0
vs Industry
22
Median 3Y
15.7
Median 5Y
15.9
Industry
17.8
vs History
vs Industry
Median 3Y
-44.5
Median 5Y
-35.1
Industry
25.4
vs History
20
vs Industry
54
Median 3Y
1.3
Median 5Y
1.5
Industry
2.2
vs History
6
vs Industry
63
Median 3Y
1.2
Median 5Y
1.4
Industry
2.8
Forward
1.6
vs History
0
vs Industry
46
Median 3Y
3.6
Median 5Y
3.8
Industry
5.4
vs History
9
vs Industry
2
Median 3Y
23.9
Median 5Y
23.9
Industry
13.7
Forward
5.6
vs History
9
vs Industry
1
Median 3Y
23.9
Median 5Y
23.9
Industry
17.2
Forward
11.6
vs History
0
vs Industry
25
Median 3Y
13.1
Median 5Y
14.2
Industry
16.5
vs History
vs Industry
Median 3Y
-60.8
Median 5Y
-38.1
Industry
19.3
vs History
9
vs Industry
54
Median 3Y
1.1
Median 5Y
1.3
Industry
2

Multiples Across Competitors

Competitors Multiples
Zhejiang Medicine Co Ltd Competitors

All Multiples
P/S
P/E
EV/EBITDA
EV/EBIT
All Countries
Close
Market Cap P/S P/E EV/EBITDA EV/EBIT
CN
Zhejiang Medicine Co Ltd
SSE:600216
16.7B CNY 2 35.4 81.1 81.1
JP
Nichi-Iko Pharmaceutical Co Ltd
TSE:4541
776 550.9T JPY 4 211 733 -5 347 888.9 -5 459 134.4 -5 046 864.6
US
Eli Lilly and Co
NYSE:LLY
761.8B USD 18.5 90.9 48.9 54.5
UK
Dechra Pharmaceuticals PLC
LSE:DPH
440.4B GBP 578.3 -15 783.5 3 846.3 17 702.3
DK
Novo Nordisk A/S
CSE:NOVO B
3.3T DKK 12.3 35 24.4 27.8
US
Johnson & Johnson
NYSE:JNJ
368.4B USD 4.2 25 12.1 15.8
US
Merck & Co Inc
NYSE:MRK
250.9B USD 4 20.6 10.4 12.5
CH
Roche Holding AG
SIX:ROG
208.8B CHF 3.6 18.2 10.2 12.1
CH
Novartis AG
SIX:NOVN
181.2B CHF 4.2 12.6 10 14.9
UK
AstraZeneca PLC
LSE:AZN
158.6B GBP 4.1 31.3 169.3 253.7
IE
Endo International PLC
LSE:0Y5F
155B USD 66.9 -53 248.3 622.6
P/E Multiple
Earnings Growth
CN
Zhejiang Medicine Co Ltd
SSE:600216
Average P/E: 33.6
35.4
154%
JP
N
Nichi-Iko Pharmaceutical Co Ltd
TSE:4541
Negative Multiple: -5 347 888.9 N/A
US
Eli Lilly and Co
NYSE:LLY
90.9
451%
UK
Dechra Pharmaceuticals PLC
LSE:DPH
Negative Multiple: -15 783.5 N/A
DK
Novo Nordisk A/S
CSE:NOVO B
35
86%
US
Johnson & Johnson
NYSE:JNJ
25
-22%
US
Merck & Co Inc
NYSE:MRK
20.6
7 336%
CH
Roche Holding AG
SIX:ROG
18.2
32%
CH
Novartis AG
SIX:NOVN
12.6
21%
UK
AstraZeneca PLC
LSE:AZN
31.3
177%
IE
E
Endo International PLC
LSE:0Y5F
Negative Multiple: -53 N/A

See Also

Discover More
Back to Top